SP

Supreme Petrochem Ltd

Q4 FY26Chemicals & Petrochemicals

Supreme Petrochem Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹698
Market cap₹13.3K Cr
P/E27.1
Updated23 Aug 2026
Read4 min read

The short version

The company expects an 8% to 10% volume growth in FY27, contingent on global market normalization by June-July 2026. The company anticipates volume growth of 8-10% for the year if global conditions, including war impacts, normalize by June-July 2026.

From Supreme Petrochem Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • The company expects an 8% to 10% volume growth in FY27, contingent on global market normalization by June-July 2026.
  • With ABS operational, overall volume growth aligns with market growth; however, Q1 FY27 might see lower growth due to ongoing global uncertainties.
  • The ABS plant currently operates at around 65-70% capacity with expectations to reach 80-90% utilization in FY27.
  • Phase two expansion of ABS is underway, independent of equipment issues, indicating future capacity increase.
  • The EPS Phase-II expansion was successfully commissioned in April 2026, increasing capacity from 85,000 to 115,000 tons per annum.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Supreme Petrochem Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • EPS Phase-II expansion at Nagothane commissioned in April 2026, increasing capacity from 85,000 to 115,000 tons per annum.
  • ABS mass plant restarted with modified arrangements, currently operating at ~65% capacity; aiming to reach 80-90% utilization in FY27.
  • Phase-II ABS expansion planned for FY28; work progressing irrespective of current equipment issues.
  • Haryana CAPEX for FY27 is limited to infrastructure and related activities due to delayed IOC styrene monomer plant; major spending on PS and EPS pending clearer commissioning timeline.

2 more points management made on capital expenditure plans

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Supreme Petrochem Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The transcript does not provide specific numerical details on the current or expected order book or pending orders for Supreme Petrochem Limited.
  • Discussions indicate ongoing demand and operations, with certain capacity utilizations (e.g., ABS plant at 65% of design capacity) and production volumes mentioned, but order backlog specifics are not disclosed.
  • Growth expectations are based on volume increases aligned with market growth (8-10% volume growth guidance mentioned).
  • Demand scenarios vary between OEM and non-OEM segments, with roughly a 50-50 split anticipated for some products.

2 more points management made on order book & pipeline

Supreme Petrochem Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.6K Cr, net profit ₹168 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Vipul Organics Ltd (Q4 FY26)

    Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) . Key concall takeaways from Vipul Organics's Q4 FY26 earnings call — and how it ranks against…

  • Chemfab Alkalis Ltd (Q4 FY26)

    Chlor Alkali segment: ₹55.63 crore (down 1.21% YoY from ₹56.31 crore) . Key concall takeaways from Chemfab Alkalis Ltd's Q4 FY26 earnings call — and how it…

  • Sudarshan Pharma Industries Ltd (Q4 FY26)

    Revenue from Operations for Q4 March 2026: ₹220.92 Cr (Page 41) . Key concall takeaways from Sudarshan Pharma Industries Ltd's Q4 FY26 earnings call — and how…

  • Innovassynth Technologies (India) Ltd (Q4 FY26)

    Order book improved by approximately INR 60 crore during the quarter, indicating strong customer demand and revenue visibility. Key concall takeaways from…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Supreme Petrochem Ltd Q4 FY26 results?

The company expects an 8% to 10% volume growth in FY27, contingent on global market normalization by June-July 2026. The company anticipates volume growth of 8-10% for the year if global conditions, including war impacts, normalize by June-July 2026.

What is Supreme Petrochem Ltd share price analysis?

Supreme Petrochem Ltd currently shows a neutral. The stock trades at a P/E of 27.1 with a market cap of ₹13,276 Cr. Investors should review the full earnings analysis for detailed insights.

Is Supreme Petrochem Ltd planning capital expenditure?

EPS Phase-II expansion at Nagothane commissioned in April 2026, increasing capacity from 85,000 to 115,000 tons per annum.

Keep Supreme Petrochem Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.